DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/d20db2\/russian_federation<\/a>) has announced the addition of GlobalData 's new report \"Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture\" to their offering. <\/p>\n GlobalData's new report, Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Russian Federation In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. <\/p>\n Scope <\/p>\n Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017. 2010 company shares and distribution shares data for each of the seven market categories. Global corporate-level profiles of key companies operating within the Russian Federation In Vitro Diagnosticsmarket. <\/p>\n Companies Mentioned: <\/p>\n F. Hoffmann-La Roche Ltd. Siemens Healthcare Abbott Laboratories bioMerieux S.A. Beckman Coulter, Inc. Ortho-Clinical Diagnostics Inc. Bio-Rad Laboratories, Inc. Sysmex Corporation Becton, Dickinson and Company DiaSorin S.p.A Alere Inc. Phadia AB Qiagen N.V. DIAGNOSTICA STAGO, Inc. Danaher Corporation Gen-Probe Incorporated PerkinElmer, Inc. HORIBA, Ltd. Thermo Fisher Scientific Inc. Grifols, S.A. Immucor, Inc. Hologic, Inc. Cellestis Limited Life Technologies Corporation Mindray Medical International Limited <\/p>\n For more information visit http:\/\/www.researchandmarkets.com\/research\/d20db2\/russian_federation<\/a> <\/p>\n<\/p>\n See the rest here: DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/d20db2\/russian_federation<\/a>) has announced the addition of GlobalData 's new report \"Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture\" to their offering. GlobalData's new report, Russian Federation In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Russian Federation In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. Continue reading
\nResearch and Markets: Russian Federation In Vitro Diagnostics Market Outlook to 2017<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"